Penumbra
PEN
#1773
Rank
C$13.10 B
Marketcap
$341.48
Share price
1.81%
Change (1 day)
7.45%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of September 2024 : C$0.31 Billion

According to Penumbra's latest financial reports the company's total debt is C$0.31 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$0.31 B-2.85%
2022-12-31C$0.31 B44.65%
2021-12-31C$0.22 B124.47%
2020-12-31C$98.53 M-8.33%
2019-12-31C$0.10 B
2018-12-31N/A
2013-12-31C$6.38 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$45.64 M-85.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.14 B 261.35%๐Ÿ‡บ๐Ÿ‡ธ USA